The market is holding on for dear life as it endures its longest slump in the last two years. In a cautious effort to shift the tides, US stocks traded slightly higher on Thursday morning. Investors, far and wide, are trying to pull the Dow out of from the wreckage after the index plunged 832 points on Wednesday. As of Thursday, the Dow crept into calmer waters, with the Nasdaq rising nearly 1%, rebounding from its workday since the introduction of Brexit in June 2016, CNN Business reports.
- The Dow (DJI) is currently down 0.74% (-$200.81) , trading at $25,40943 per share, with
- The S&P 500 Index (SPX) dropped 0.58% ($-18.77), trading at $2,767.82 per share following suit.
The Nasdaq in specific has been riding the struggle bus the last few days, losing 7% to date. Over the course of this week, the Federal Reserve has raised interest rates to protect the economy from inflation, resulting in a mass selloff of bonds, leading to increases in yields on government bonds, specifically the 10-year Treasury note. The Nasdaq index contains many tech stocks, and many tech companies are facing the consequences of the index’s plunge.
Companies like Netflix (NFLX), Amazon (AMZN), Facebook (FB), and others have dropped significantly this week. The New York Stock Exchange’s FANG+ index includes all of these companies as well as Tesla (TSLA), Nvidia (NVDA), and China’s Alibaba (BABA). This last week, the FANG+ index dropped 8%, causing many of its tech holdings to plummet.
- Netflix (NFLX) dropped more than 8%, trading at $325.55 per share
- Amazon (AMZN) sank nearly 10% in the past few days, trading at $1,730.88 per share
- Facebook (FB) and Apple (AAPL) each dropped 4% this week, trading at $153.59 and $217.34, respectively
While all signs are showing that each of these companies will report relatively strong quarterly earnings, they are not impervious to the recent downtick in long-term bond yields and signs from the Reserve that “it plans to keep hiking short-term rates throughout 2019,” according to CNN. This could effectively stifle the economy and harm the growth of these tech giants.
Chris Zaccarelli, chief investment officer for Independent Advisor Alliance, commented on the rising rates’ effect on the tech industry:
“The first thing to fall will be these momentum names. I think there are a lot of risks overhanging the market. We’re in a rising state environment, and it’s not just that they’re higher, but that they rose so quickly…Rising rates will disproportionately affect the tech sector.”
–Chris Zaccarelli, chief investment officer Independent Advisor Alliance.
Though the fiscal integrity of the technology sector seems compromised, Zaccarelli said that we have no reason to believe the industry’s headed “for bear market territory and that there’s no reason to panic.”
Why tech, why now?
Generally, the majority of tech companies traded on Wall Street are considered to be “growth investments.” This means that investing in these companies will not pay any dividends when the company reinvests their earnings in their own growth. Netflix (NFLX), for example, uses a large amount of its capital each quarter producing and obtaining new content, CNBC reports, as well as driving subscriber growth overseas. Like Netflix, Amazon (AMZN) reinvests a large percentage of its capital into new business ventures, like Amazon Web Services.
However, these investments can be riskier in the short run because investor capital is directly proportionate to the company’s share price.
As trade tensions between the U.S. and China constantly increase, the Chinese economy is starting to show signs of slowing. Last month, President Donald Trump issued 10% tarries on $200 billion worth of Chinese goods, with provisional agreements for those tariffs to hit almost 25% by the end of the year.
Companies like Qualcomm (QCOM) and Intel (INTC) are facing the consequences of President Trump’s China tariffs. China is one of the industry’s leading producers of semiconductor equipment, technology integral to the production of mass-market electronics. If the production of semiconductors decreases, the global tech industry will be in trouble.
The fact of the matter is the market will always ebb and flow, it’s the nature of the industry. If the Federal Reserve continues to increase interest rates, tech companies may need to step to the side, while other industries combat the rising bond yields.
Biotechnology Could Cure It All
Nearly two-thousand years ago, give or take several minutes, Hippocrates taught that human existence was centered around the four elements — earth, water, fire, and air — which in the human body was represented by the four basic humors: blood, phlegm, black bile, yellow bile. Hippocrates explained that each humor was located in a specific organ of the human body and each related to its own personality type — sanguine, phlegmatic, melancholic, and choleric.
‘Therefore, if someone was sick, Hippocrates taught that this indicated an imbalance in one of the four
Suffice to say that the medical field has moved forward since 460 BC, and recently, these advancements have occurred in the biotechnology industry. Though biotech is a relatively new field, it possesses great potential for the future of medicine. One of the more recent breakthroughs in biotech stems from something called pharmacogenomics, or the study of how genetics affect a person’s response to drugs. This new field combines the science of developing drug treatments and research conducted on human genetics and their functions.
According to the U.S. National Library of Medicine, most drugs currently available on the market are branded as “one size fits all,”meaning that this specific treatment was created to cure a certain ailment for anyone who takes it. However, as scientists in the pharmacogenomics field are discovering, not everyone reacts the same to certain drugs.
For example, if two individuals are having an allergic reaction and both ingest an anti-histamine, it’s possible that it will help one person feel better, while causing adverse side-effects to the other person. By studying a person’s genetic coding, medical experts are better able to predict how a medication will effect a particular person.
Ironically enough, as new technologies and inventive approaches to curing diseases come to light, medical researchers are discovering new diseases that seek to test all the progress we’ve made thus far. The practices of medicine have taken massive strides over the past few generations through the pioneering of biotechnology research and other incredible advancements, but regardless of these steps forward, it is up to companies in the healthcare industry to responsibly tend to the needs of their patients.
Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI) / (6PH.F) is a Canadian publicly traded company strategically poised to take advantage of lucrative business opportunities in the global healthcare industry. The Company is working to develop innovative healthcare approaches that combine human skill-based expertise with emerging technologies. What sets the Company apart from others in the field is that Premier is focused on developing their healthcare platform with a patient centric focus, looking to restore power back to the patients. For far too long, patients have been at the mercy of pharmaceutical companies who, by virtue of their capital, have maintained a chokehold on the price of drugs that patients need to stay healthy.
In addition to rising treatments costs, as the global population increases, there are less primary physicians available for consumers looking to be cured. Through the use of Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI) / (6PH.F) HealthVue app, patient can see their physician, access their charts & lab results, chat securely with clinical staff, reorder prescriptions and share remote health monitoring data with their doctor – all at their fingertips. The HealthVue app utilizes a virtual care platform designed to be easy to use and to improve a patient’s access to primary care.
In addition these advanced healthcare solutions, the Company shared, in their most recent corporate update, that they plan on utilizing artificial intelligence to assist in virtually triaging the needs of their patients. Using their Healthvue app, the patient will answer a series of questions which will be relayed to the physician, along with a differential on possible diagnoses. This information will be pre-populated to the physicians charting system and will provide key patient information prior to the scheduled virtual visit, saving them a considerable amount of time and allowing more time for patient interaction.
Pursuant to an agreement between MIDAM VENTURES, LLC and Premier Health Group Inc. we were hired for a period from 10/1/2018 – 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $300,000 ( CASH) for & were paid “500,000” shares of restricted common shares (as of 1/2/2019). We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 we plan to sell the “500,000” shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Please click here for full disclaimer.
Stock Price Newsletter – February 21, 2019
Mueller Investigation Is Almost Ready
A half-witted, know-nothing playwright by the name of William Shakespeare once wrote that “these violent delights have violent ends.” The line, taken from Shakespeare’s Romeo and Juliet, also featured in Westworld, depicts a scene in which Friar Laurence cautions Romeo into falling for Juliet because his love may catalyze his own violent end. I attribute the words of Shakespeare to the current predicament facing President Donald Trump and his administration. In the two or so years since Trump took office, special counsel Robert Mueller has worked without end to investigate whether the Trump administration colluded in any way, shape, or form, with Russia during the 2016 presidential election.
After countless subpoenas and inducements of former Trump associates and administration members, sources indicate that Mueller’s long nights away from the family could soon be over. Towards that end of January, Roger Stone, a former associate of Donald Trump before he became president, was indicted on charges of seeking stolen emails from WikiLeaks that could damage Trump’s opponents during the 2016 presidential election season.
Per the official language of the indictment:
“…After the 2016 U.S. presidential election, the U.S. House of Representatives Permanent Select Committee on Intelligence, the U.S. Senate Select Committee on Intelligence, and the Federal Bureau of Investigation opened or announced their respective investigations into Russian interference in the 20126 U.S. presidential election…Stone took steps to obstruct these investigations….He made false statements to the HPSCI about his interactions regarding WikiLeaks, and falsely denied possessing records that contained evidence…”
-Robert Stone indictment
The indictment went on to explain that Stone attempted to persuade a witness to provide false testimony and withheld pertinent information from federal investigators. According to several sources, Stone was arrested by the FBI Friday morning while drinking his morning coffee at his home in Florida. Stone’s attorney immediately attempted to defuse any public sentiment stirring up connecting Stone to special counsel Mueller’s investigation, suggesting that Stone’s indictment “focuses on allegedly false statements…made to Congress,” and has nothing to do with Russian collusion.
According to CNN, Attorney General Bill Barr is limbering up in preparation to announce as early as next week the completion of Robert Mueller’s investigation, “with plans for Barr to submit to Congress soon after a summary” of the confidential report is prepared. Interestingly enough, though the details of the report concern both the American people and its presiding government, under special counsel regulations, Mueller must submit his “report” to the attorney general and the law doesn’t require this document to be shared with anyone.
Barr is under no formal obligation to publicly share the report, but I can already assume that members of the Democratic leadership will be banging on his office door until he throws them a bone.
The question on everyone’s mind is, what Mueller discovered in his lengthy investigation. Mueller was appointed to the case on May 17, 2017, and in years following this date, Mueller has had his hands full. Early last week, Mueller’s office filed its sentencing memorandum against Paul Manafort, Trump’s former campaign manager, who will be sentenced next month in federal district court in the District of Columbia.
“For a decade, Manafort repeatedly violated the law. Considering only the crimes charged in this district, they make plain that Manafort chose to engage in a sophisticated scheme to hide millions of dollars from United States authorities. The sentence in this case must take into account the gravity of this conduct, and serve to both specifically deter Manafort and those who would commit a similar series of crimes.”
–sentencing memo from Robert Mueller
As for the findings of Mueller’s investigation, we will have to wait and see how Attorney General Barr chooses to go about sharing the report, if he ends up sharing the information at all. The information could disturb the Trump presidency and possibly give Democrats grounds for introducing articles of impeachment.
Search Stock Price (StockPrice.com)
Editorials2 months ago
Multi-Trillion Dollar Industry Providing Massive Opportunity in 2019 & Beyond
Featured4 months ago
Opportunity Ahead → Telemedicine the Future of Primary Care
Sponsored Content4 months ago
Special Delivery! On-Demand Tech Companies Hit Billion-Dollar Valuations; Here’s How Investors Can Capitalize In The Market
Featured4 months ago
Premier Health Group Inc. (OTC: PHGRF) (CSE: PHGI) Announces Plans to Enter Canadian Pharmacy & Drug Store Market
Newsletter4 months ago
Stock Price: Newsletter Tuesday 11/5/2018
Editorials5 months ago
2 NAFTA 2 Furious!
Editorials5 months ago
Brews with Brett; Why the Supreme Court Nominee’s Favorite Drink May Be His Downfall
Editorials5 months ago
China Offers New “Spy-cy” Chip Flavor, Apple & Amazon Can’t Stand Heat